BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

Illustration of cancer cells and immunotherapy treatment

Resveratrol-triggered switches maximize cancer immunotherapy, reduce toxicity

Aug. 11, 2021
By John Fox
Resveratrol-triggered genetic switches, which can control in vivo tumor-targeted chimeric antigen receptor T-cell (CAR T) therapy, have been developed by Chinese researchers, who demonstrated that the new tools enabled maximized in vivo immunotherapeutic efficacy while minimizing toxicity.
Read More
Graphene illustration

Graphene coating may prevent the formation of biofilms on medical implants

Aug. 10, 2021
By Nuala Moran
LONDON – Swedish researchers have devised a method for binding insoluble antibiotics to graphene coatings, in an advance that could prevent the formation of biofilms on medical implants. In comparison to other long-winded methods for loading antibiotics onto implant surfaces, they say the way in which they bind active molecules to graphene is simple and could easily be integrated into manufacturing processes.
Read More
Silhouette of head, brain

Stress hormones affect brain plasticity via distinct mechanisms

Aug. 10, 2021
By Anette Breindl
Researchers have shown that glucocorticoids, a type of steroid hormones, target both neuroplasticity-related genes and genes related to ciliary function in the brain. However, the effects on the different processes are mediated via different receptors, and in response to different stimuli. A study investigated the specific targets of glucocorticoids, giving new insights into the biological mechanisms of stress adaptations, and how they are linked to neural plasticity.
Read More
T cells

T-cell exhaustion is durable, but specific

Aug. 9, 2021
By Anette Breindl
It's a good news, bad news scenario for exhausted T cells in chronic infections. Multiple groups of investigators reported in the July 26, 2021, online issue of Nature Immunology that even after a chronic hepatitis C virus infection was cured, T cells that had become dysfunctional during the infection retained epigenetic "scars" that prevented them from becoming fully functional memory T cells.
Read More
Neural network

Proteins found to promote neuroinflammation in MS

Aug. 9, 2021
By John Fox
Immunologists at Sun Yat-sen University in Guangzhou, China, have been the first to show that interferon-induced protein 35 family proteins promote neuroinflammation and multiple sclerosis (MS), as they reported in the August 2, 2021, edition of Proceedings of the National Academy of Sciences.
Read More
Gloved hand holding petri dish in lab

Nullifying necrosis: unfolded protein response inhibitors fight flesh-eating bacteria

Aug. 6, 2021
By Subhasree Nag
Researchers led by Emanuel Hanski at the Hebrew University of Jerusalem have identified a class of molecules that inhibit endoplasmic reticulum (ER) stress and could decrease mortality in mice infected with Streptococcus pyogenes, also known as the group A streptococci.
Read More
Microscope and coronavirus illustration

New study is both reality check and shot in the arm for SARS-CoV-2 drug repurposing

Aug. 5, 2021
By Anette Breindl
Investigators at the University of California at San Francisco have identified a confounder that appears to be behind the purported anti-SARS-CoV-2 effects of a number of therapeutic candidates that were identified via repurposing.
Read More
Doctor and patient consultation

GWAS gives clues to menopause, and healthy aging

Aug. 5, 2021
By Nuala Moran
A genome-wide association study has identified 290 genetic variants, including a wide range of DNA damage response genes, that are associated with age at menopause.
Read More
Microscope and coronavirus illustration

New study is both reality check and shot in the arm for SARS-CoV-2 drug repurposing

Aug. 4, 2021
By Anette Breindl
Investigators at the University of California at San Francisco have identified a confounder that appears to be behind the purported anti-SARS-CoV-2 effects of a number of therapeutic candidates that were identified via repurposing.
Read More
Brain and blood cells

Hong Kong researchers develop blood test for Alzheimer’s disease

Aug. 3, 2021
By Elise Mak
Researchers from The Hong Kong University of Science and Technology (HKUST) have developed a blood test to detect Alzheimer’s disease (AD) early. They said the test has an accuracy level of over 96% and can also monitor disease progression. This is a new approach to detecting AD compared to the commonly used cognitive tests and invasive methods that detect changes in the brain caused by AD.
Read More
Previous 1 2 … 89 90 91 92 93 94 95 96 97 … 198 199 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing